The Type 1 Diabetes Prevention Trial, also known as the Intranasal Insulin Trial (INIT II), is part of a coordinated global effort to develop a vaccine for type 1 diabetes. The trial, which began in 2006, is jointly funded by the National Health and Medical Research Council (NHMRC) and the Juvenile Diabetes Research Foundation (JDRF), through the Diabetes Vaccine Development Centre (DVDC).

If successful, this vaccine could prevent type 1 diabetes and the need for daily >> Find out more

  • Are you Eligible?

    Anyone who is aged between 4 and 30 and has type 1 diabetes in his or her family can potentially participate in the Type 1 Diabetes Prevention Trial. Get involved today and write yourself in
    >> Find out more

  • Spread the Word

    Click the icons below to email a friend or spread the word via Facebook or Twitter. The green ShareThis icon also lets you tell your friends via LinkedIn, Google and Yahoo! So, no excuses!

  • Learn About Diabetes

     Type 1 diabetes, previously known as juvenile or early-onset diabetes, is an autoimmune disease in which the body's immune system destroys the cells that produce insulin. Located in the pancreas, these cells are called beta cells. Although less co
    >> Find out more

  • Resources

     Help us spread the word! Download the Type 1 Diabetes Prevention Trial resources here and start telling you patients, colleagues, family and friends about the trial today.
    >> Find out more